Wikidata

(Q64352680)

English

Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)

clinical trial

In more languages

Statements

title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis (English)
0 references
medical condition
eczema
0 references
dermatitis
0 references
country
Canada
0 references
start time
December 2013
0 references
end time
December 2014
0 references
number of participants
54
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64352680&oldid=1857678291"